Prefilled Syringes Market Size, Security & Analysis Pr - PowerPoint PPT Presentation

About This Presentation
Title:

Prefilled Syringes Market Size, Security & Analysis Pr

Description:

The global prefilled syringes market is estimated to garner a revenue of about USD 16100 Million by the end of 2033 by growing at a CAGR of ~12% over the forecast period, i.e., 2023 – 2033. – PowerPoint PPT presentation

Number of Views:3
Slides: 5
Provided by: Philipusa
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Prefilled Syringes Market Size, Security & Analysis Pr


1
Global Prefilled Syringes Market to be Propelled
by Rising Cases of HIV, Higher Capital Influx in
Prefilled syringes, Increased Prevalence of
Biologic Drugs and Higher Risk of Infection from
Needle by CAGR of 12 During 2023
2033 Kenneth Research published a report titled
Prefilled Syringes Market Global Demand
Analysis Opportunity Outlook 2033 which
delivers detailed overview of the global
prefilled syringes market in terms of market
segmentation by application, material, design,
and by region. Further, for the in-depth
analysis, the report encompasses the industry
growth indicators, restraints, supply and demand
risk, along with detailed discussion on current
and future market trends that are associated with
the growth of the market.
2
The global prefilled syringes market is to grow
at a CAGR of approximately 12 over the forecast
period i.e. 2023-2033. On the basis of
application, the global prefilled syringes
market is segmented into diabetes, multiple
sclerosis, anaphylaxis, cancer and others. Out of
all, the diabetes segment is to garner a
significant revenue by the end of 2033. This
growth is expected on the account of increased
number of diabetic patient and higher demand of
insulin injections. For more descriptions_at_https//
www.kennethresearch.com/report-
details/prefilled-syringes-market/10352443 The
global prefilled syringes market is expected to
grow by growing demand of vaccine of coronavirus
followed by increased cases of HIV and Hepatitis.
Moreover, higher pervasion of biologics drug,
increased investment for the prefilled syringes
and higher risk of infections caused by re-using
needles are few factors expected to elevate the
market growth. The global prefilled syringes
market is estimated to garner a revenue of about
USD 16100 Million by the end of 2033, up from a
revenue of around USD 5900 Million in the year
2022. On the basis of region, the global
prefilled syringes market is segmented into
North America, Europe, Asia Pacific, Latin
America and Middle East Africa region. The
market in Europe is to grow at a significant CAGR
over the forecast period and expected to
generate the highest revenue by the end of 2033.
Surging capital influx by companies, and higher
vaccination drive is to propel the growth of
market in Europe. The research is global in
nature and covers detailed analysis on the market
in North America (U.S., Canada), Europe (U.K.,
Germany, France, Italy, Spain, Hungary, Belgium,
Netherlands Luxembourg, NORDIC Finland,
3
Sweden, Norway, Denmark, Poland, Turkey, Russia,
Rest of Europe), Latin America (Brazil, Mexico,
Argentina, Rest of Latin America), Asia-Pacific
(China, India, Japan, South Korea, Indonesia,
Singapore, Malaysia, Australia, New Zealand,
Rest of Asia-Pacific), Middle East and Africa
(Israel, GCC Saudi Arabia, UAE, Bahrain,
Kuwait, Qatar, Oman, North Africa, South
Africa, Rest of Middle East and Africa). In
addition, analysis comprising market size, Y-O-Y
growth opportunity analysis, market players
competitive study, investment opportunities,
demand for future outlook etc. has also been
covered and displayed in the research
report. Heavy Investment Influx for the
Production of Prefilled Syringes is to Elevate
the Market Growth Higher demand for prefilled
syringes, owing to technological advancement,
its uses to cure cancer, asthma and allergies has
propelled companies to invest more in the
prefilled syringes and boost its manufacturing.
In 2020, BD declared to invest about USD 1
billion for the manufacturing of prefilled
syringes. However, impurity and leakage issue of
syringes, risk of embolism while injecting and
stringent rules and regulations hindering
manufacturing are few factors which are expected
to operate as key restraint to the growth of the
global prefilled syringes market over the
forecast period. This report also provides the
existing competitive scenario of some of the key
players of the global prefilled syringes market
which includes company profiling of Abbott,
Bayer Pharmaceuticals, Baxter BioPharma
Solutions, BG (Becton, Dickinson and Company),
Gerresheimer AG, Medtronic, Nipro Pharma
Corporation, Terumo Medical Corporation, Vetter
Pharma International GmbH, West Pharmaceutical
Services, Inc., and others. The
4
profiling enfolds key information of the
companies which encompasses business overview,
products and services, key financials and recent
news and developments. On the whole, the report
depicts detailed overview of the global
prefilled syringes market that will help industry
consultants, equipment manufacturers, existing
players searching for expansion opportunities,
new players searching possibilities and other
stakeholders to align their market centric
strategies according to the ongoing and expected
trends in the future. Request Report Sample_at_
https//www.kennethresearch.com/sample-
request-10352443 Kenneth Research is a leading
service provider for strategic market research
and consulting. We aim to provide unbiased,
unparalleled market insights and industry
analysis to help industries, conglomerates and
executives to take wise decisions for their
future marketing strategy, expansion and
investment etc. We believe every business can
expand to its new horizon, provided a right
guidance at a right time is available through
strategic minds. Our out of box thinking helps
our clients to take wise decision in order to
avoid future uncertainties. Contact for more
Info AJ Daniel Email sales_at_kennethresearch.com
U.S. Phone 1 313 462 0609
Write a Comment
User Comments (0)
About PowerShow.com